Special Statutory Funding Program for Type 1 Diabetes Research: Evaluation Report, January 2011
Evaluation Report on the Special Statutory Funding Program for Type 1 Diabetes Research (January 2011)
Special Statutory Funding Program for Type 1 Diabetes Research: Evaluation Report describes the unique, collaborative, and innovative research consortia, networks, and resources that have been enabled by the Special Statutory Funding Program for Type 1 Diabetes Research (Program). The Program was established by the Congress for research into the prevention and cure of type 1 diabetes. The Report describes the collaborative planning process guiding use of the funds, the research progress achieved to date, the expected future accomplishments of the research programs, and emerging research opportunities. As described in this publication, the Program has fostered many significant scientific accomplishments, including the creation of several large-scale, high-impact research efforts which have provided new insights into the understanding of type 1 diabetes and its complications, and contributed to improving the health and quality of life of people with type 1 diabetes. In addition, the Report contains “Investigator Profiles” to highlight type 1 diabetes researchers whose studies have been supported by the Program, and profiles of people who are participating in clinical research supported by the Program. A version of this Report was submitted to the Congress in December 2010.
Electronic Version (PDF): The Evaluation Report on the Special Statutory Funding Program for Type 1 Diabetes Research is now available in PDF (Adobe Acrobat® Reader 
for viewing)
|
Complete Report by Chapter:
Cover ( PDF, 315 KB )
Legislative History ( PDF, 54 KB)
Table of Contents ( PDF, 60 KB )
Overview ( PDF, 448 KB )
Goal I: Identify the Genetic and Environmental Causes of Type 1 Diabetes ( PDF, 878 KB )
Goal II: Prevent or Reverse Type 1 Diabetes ( PDF, 1.1 KB )
Goal III: Develop Cell Replacement Therapy ( PDF, 2.2 MB )
Goal IV: Prevent or Reduce Hypoglycemia in Type 1 Diabetes ( PDF, 805 KB )
Goal V: Prevent or Reduce the Complications of Type 1 Diabetes ( PDF, 859 KB )
Goal VI: Attract New Talent and Apply New Technologies to Research on Type 1 Diabetes ( PDF, 805 KB )
Appendix A: Allocation of the Special Diabetes Program ( PDF, 587 KB )
Appendix B: Assessment of the Special Diabetes Program ( PDF, 1.2 MB )
Appendix C: Evaluation of Major Research Consortia, Networks, and Resources ( PDF, 749 KB )
Appendix D: Type 1 Diabetes Consortia Coordination ( PDF, 179 KB )
Appendix E: Supplemental Material on Scientific Conferences, Workshops, and Meetings Relevant to Type 1 Diabetes and its Complications
( PDF, 204 KB )
Appendix F: Advances and Emerging Opportunities in Diabetes Research: A Strategic Planning Report of the Diabetes Mellitus Interagency Coordinating Committee ( PDF, 348 KB )
Appendix G: Acronyms and Abbreviations ( PDF, 181 KB )
Acknowledgements ( PDF, 200 KB ) |
Print Version: Single copies are available for free (no bulk orders).
I would like to request my printed copy now. (Please include your name and mailing address with zipcode in the body of email.)
If you would like to request a printed copy, please contact the National Diabetes Information Clearinghouse at:
National Diabetes Information Clearinghouse
1 Information Way
Bethesda, MD 20892-3560
Phone: 1-800-860-8747
Fax: 703-738-4929
TTY: 1-866-569-1162
Email: ndic@info.niddk.nih.gov
(Please specify that you are requesting "2011 T1D Evaluation Report " and include your name, mailing address, telephone number, and email address.)
* Documents in PDF format require the free Adobe Acrobat® Reader application for viewing.
Page last updated: February 07, 2012
